De Novo Review Blog

How the SCOTUS decision in Merck v. Albrecht impacts plaintiffs

On May 20, 2019, the U.S. Supreme Court held that the judge, not the jury, must decide whether state-law failure-to-warn claims are preempted by federal law on the ground that there is “clear evidence” that the U.S. Food and Drug Administration (FDA) would not have approved the warning that state law requires. Litigation resulting from […]

Read More »

What All Lawyers Should Know About the Prescription Opioid Litigation

The Crisis On average, 130 Americans die every day from opioid overdose. With more than 500,000 opioid-related deaths recorded in the U.S. between 2000 and 2015, the crisis was officially declared a public health emergency by President Trump. Opioids are prescription narcotics with properties similar to those of opium and heroin. While opioids are used […]

Read More »